Search

everythinglearnresearchcommunity

for

Search:↓

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

Antioxidants may help fight oxidative stress linked to autoimmune skin diseases.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Advanced human skin models improve drug development and could replace animal testing.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

Doctors need to be better prepared to assess and treat obesity in patients.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

Cuscuta reflexa extract may help treat hair loss caused by hormones.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

HIV can cause various severe or unusual skin conditions that help indicate the presence and stage of the disease.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.